Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis

Critical Care Medicine

Volumn 35, Issue 10, 2007, Pages 2337-2343

  Barrett, Lucinda K ^a,b   Orie, Nelson N ^b   Taylor, Valerie ^a,b   Stidwill, Raymond P ^a,b   Clapp, Lucie H ^b   Singer, Mervyn ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Mesenteric artery; Myography; Norepinephrine; Rat; Septic shock; Vasopressin

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; F 180; HORMONE RECEPTOR STIMULATING AGENT; HYPERTENSIVE FACTOR; NORADRENALIN BITARTRATE; SODIUM; UNCLASSIFIED DRUG; UREA; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BIOCHEMISTRY; BLOOD OSMOLARITY; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; EX VIVO STUDY; EXPERIMENTAL MODEL; FLUID RESUSCITATION; HORMONE DETERMINATION; HYPOTENSION; IN VIVO STUDY; MALE; MESENTERIC ARTERY; MORTALITY; MYOGRAPHY; NONHUMAN; NORADRENALIN BLOOD LEVEL; PERITONITIS; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SEPSIS; VASOPRESSIN BLOOD LEVEL; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; NOREPINEPHRINE; RATS; RATS, WISTAR; SHOCK, SEPTIC; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASOMOTOR SYSTEM; VASOPRESSINS;

EID: 34748877743     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000281861.72907.17     Document Type: Article

References (43)

1. Holmes CL: Vasoactive drugs in the intensive care unit. Curr Opin Crit Care 2005; 11:413-417
2. Beale RJ, Hollenberg SM, Vincent JL, et al: Vasopressor and inotropic support in septic shock: An evidence-based review. Crit Care Med 2004; 32:S455-S465
3. Abboud FM, Floras JS, Aylward PE, et al: Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels 1990; 27:106-115
4. Landry DW, Levin HR, Gallant EM, et al: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-1282
5. Malay MB, Ashton RC Jr, Landry DW, et al: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47:699-703
6. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
7. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209-1210
8. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
9. Sharshar T, Blanchard A, Paillard M, et al: Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31:1752-1758
10. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-595
11. Dunser MW, Hasibeder WR, Wenzel V, et al: Endocrinologic response to vasopressin infusion in advanced vasodilatory shock. Crit Care Med 2004; 32:1266-1271
12. Jochberger S, Mayr VD, Luckner G, et al: Serum vasopressin concentrations in critically ill patients. Crit Care Med 2006; 34:293-299
13. Sutherland AM, Gordon AC, Russell JA: Are vasopressin levels increased or decreased in septic shock? Crit Care Med 2006; 34:542-543
14. Brackett DJ, Schaefer CF, Tompkins P, et al: Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 1985; 17:273-284
15. Schaller MD, Waeber B, Nussberger J, et al: Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol 1985; 249:H1086-H1092
16. Giusti-Paiva A, de Castro M, Antunes-Rodrigues J, et al: Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 2002; 30:1306-1310
17. Baker CH, Sutton ET, Zhou Z, et al: Microvascular vasopressin effects during endotoxin shock in the rat. Circ Shock 1990; 30:81-95
18. O'Brien AJ, Stidwill R: In vivo and in vitro differences in responses to catecholamines and vasopressin in rat models of LPS. Abstr. Intensive Care Med 2002; 28:S96
19. Westphal M, Stubbe H, Sielenkamper AW, et al: Terlipressin dose response in healthy and endotoxemic sheep: Impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003; 29:301-308
20. Hollenberg SM, Tangora JJ, Piotrowski MJ, et al: Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Crit Care Med 1997; 25:869-873
21. Albert M, Losser MR, Hayon D, et al: Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med 2004; 32:1891-1898
22. Bennett T, Mahajan RP, March JE, et al: Regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats. Br J Anaesth 2004; 93:400-407
23. Tarpey SB, Bennett T, Randall MD, et al: Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats. Br J Pharmacol 1998; 123:1367-1374
24. Hamu Y, Kanmura Y, Tsuneyoshi I, et al: The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastroepiploic arteries in vitro. Anesth Analg 1999; 88:542-548
25. Leone M, Boyle WA: Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Crit Care Med 2006; 34:1126-1130
26. Brealey D, Karyampudi S, Jacques TS, et al: Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286:R491-R497
27. Barrett LK, Clapp LH, Singer M: Vasopressin: Mechanisms of action on the vasculature in health and septic shock. Crit Care Med 2007; 35:33-40
28. Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41:19-26
29. Pajovic SB, Pejic S, Stojiljkovic V, et al: Alterations in hippocampal antioxidant enzyme activities and sympatho-adrenomedullary system of rats in response to different stress models. Physiol Res 2006; 55:453-460
30. Cisowska-Maciejewska A, Ciosek J: Galanin influences vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of salt loaded rats. J Physiol Pharmacol 2005; 56:673-688
31. Brackett DJ, Schaefer CF, Wilson MF: The role of vasopressin in the maintenance of cardiovascular function during early endotoxin shock. Adv Shock Res 1983; 9:147-156
32. Holmes CL, Patel BM, Russell JA, et al: Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120:989-1002
33. Mutlu GM, Factor P: Role of vasopressin in the management of septic shock. Intensive Care Med 2004; 30:1276-1291
34. Sharshar T, Carlier R, Blanchard A, et al: Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002; 30:497-500
35. Giusti-Paiva A, Elias LL, Antunes-Rodrigues J: Inhibitory effect of gaseous neuromodulators in vasopressin and oxytocin release induced by endotoxin in rats. Neurosci Lett 2005; 381:320-324
36. Carnio EC, Stabile AM, Batalhao ME, et al: Vasopressin release during endotoxaemic shock in mice lacking inducible nitric oxide synthase. Pflugers Arch 2005; 450:390-394
37. Leng G, Brown CH, Russell JA: Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 1999; 57:625-655
38. Cowley AW Jr: Vasopressin and cardiovascular regulation. Int Rev Physiol 1982; 26:189-242
39. Holmes CL, Landry DW, Granton JT: Science review: Vasopressin and the cardiovascular system part 1. Receptor physiology. Crit Care 2003; 7:427-434
40. 2+ entry channels involved in contractions of rat aorta induced by endothelin-1, noradrenaline, and vasopressin. J Cardiovasc Pharmacol 2002; 40:265-276
41. Steendijk P: Sepsis and intracellular calcium homeostasis, a sparkling story. Crit Care Med 2005; 33:688-690
42. Roth BL, Spitzer JA: Altered hepatic vasopressin and alpha 1-adrenergic receptors after chronic endotoxin infusion. Am J Physiol 1987; 252:E699-E702
43. Bucher M, Hobbhahn J, Taeger K, et al: Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 2002; 282:R979-R984